"Leading With Innovation, Innovative Therapies Inc. (ITI) Seeks Top Podiatry and Plastic Surgeons' Insights to Help Patients Requiring Negative Pressure Wound Therapy (NPWT) Receive Better Care"  
3/18/2013 10:32:40 AM

GAITHERSBURG, Md., March 18, 2013 /PRNewswire/ -- Innovative Therapies is making significant strides in advancing the science behind Negative Pressure Wound Therapy (NPWT). The company recently held a "think tank" medical forum of top Podiatry and Plastic Surgeons to discuss how to overcome the medical burden of wounds requiring NPWT. Modern NPWT has been in practice since the late 1970's when plastic surgeon Dr. Paul Svedman began treating patients. It is estimated that over half a million patients in the United States receive NPWT every year, but that millions more would benefit from the therapy if it were more accessible.


New treatment options are critical to continue advancement of the field to save patients with chronic suffering of open wounds but there are many questions about variables such as usage of instillation and antimicrobial solutions. An elite group of surgeons and Innovative Therapies' executive team met in a medical forum to discuss the future applications of NPWT and how the needs of the overall population as well as the indigent population can be served more effectively.

Dr. Sandra Berriman, VP of Medical Affairs, (, stated "Innovative Therapies is preparing to launch the new Quantum device which has a unique and patented simultaneous irrigation system. We believe that the ability to deliver solutions, whether saline or antimicrobial therapy, to an infected wound while never sacrificing negative pressure is going to create improved clinical value for patients and caregivers."

Dr. Larry Lavery D.P.M., Professor of Plastic Surgery at UT Southwestern, Dallas, Texas stated, "We are thrilled to be part of the clinical program at Innovative Therapies as we advance the science of wound care."

This was the second in a series of scientific forums that ITI will be supporting as part of its continuing effort to advance state-of-the-art wound therapy.

SOURCE Innovative Therapies Inc